Item 8.01 Other Events

On January 8, 2009, World Heart Corporation issued a press release announcing that it has submitted an Investigational Device Exemption application to the US Food and Drug Administration for a pivotal Bridge-to-Transplant study of the Levacor™ Ventricular Assist Device. A copy of the press release is attached as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

The following exhibit is being furnished herewith:

Exhibit No. Description of Exhibit.

99.1 Press release, dated January 8, 2009

---